Cancer Advances Rely on U.S. Funding: Report
WEDNESDAY, Sept. 12, 2018 (HealthDay News) — Almost two dozen new cancer treatments received U.S. Food and Drug Administration approval in the past year, a new report reveals. These treatments include innovative immunotherapies that target cancer cells (called CAR T-cell therapies) and targeted radiotherapies, according to the report from theContinue Reading